Lowering Blood Sugar Without Weight Loss | Dr Nicola Guess

What It Covers

Dr. Nicola Guess, Oxford dietitian and researcher, presents evidence that high-protein, low-carbohydrate diets can lower blood glucose in type 2 diabetes by more than medications — approximately 4 mmol/L postprandially — without any weight loss, offering an alternative pathway for the 60-65 age group who cannot or will not lose 10 kilograms.

Key Questions Answered

• •High-protein diet threshold: Targeting 30% of daily calories from protein activates amino acid sensors in pancreatic beta cells that remain functional in type 2 diabetes even when glucose sensors have failed. This mechanism produces sufficient insulin secretion to lower postprandial glucose by roughly 4 mmol/L — a reduction exceeding what most glucose-lowering medications achieve — without requiring calorie restriction or weight loss.
• •Protein source flexibility: The type of protein — animal or plant-based — produces no meaningful difference in insulin secretory response. Combining a lean protein like chicken or fish with legumes such as lentils or chickpeas adds approximately 8 grams of protein per serving while simultaneously delivering viscous fiber, which independently reduces fasting glucose by improving liver insulin sensitivity and slows postprandial glucose absorption.
• •Viscous fiber for fasting glucose: Fibers found in oats and legumes — including psyllium husk supplements — form a gel in the stomach that slows glucose absorption postprandially and improves insulin sensitivity in both adipose and muscle tissue. For people with type 2 diabetes targeting fasting glucose specifically, legume-derived fiber shows the strongest signal for reducing hepatic glucose output, suggesting improved liver insulin sensitivity.
• •Fat quality over quantity: Replacing saturated fats from sources like butter with polyunsaturated fats produces measurable reductions in liver fat and internal fat, though the effect size is modest. Monounsaturated fats show a separate signal for reducing fasting glucose in controlled ward studies. The PREDIMED trial demonstrated that a Mediterranean diet supplemented with nuts or olive oil reduced type 2 diabetes incidence without significant weight loss.
• •Waist circumference as primary metabolic marker: Among all routine clinical measures — including HbA1c, LDL cholesterol, blood pressure, and resting heart rate — waist circumference is the single most informative indicator of metabolic dysfunction. Excess visceral fat signals likely ectopic fat deposition in the liver and pancreas. Reduction in waist circumference reliably predicts improvement across all other metabolic markers, making it the most practical monitoring tool for most patients.
• •GLP-1 medications and muscle mass: Concerns about GLP-1 drugs destroying muscle are not supported by emerging clinical data. While absolute lean mass decreases during weight loss, the proportion of body weight from lean mass increases as fat mass falls faster. Relative strength and functional capacity improve post-treatment. No GLP-1 receptors exist on muscle or bone cells, meaning any lean mass changes reflect general weight loss physiology rather than a drug-specific mechanism.